Active Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Active Biotech has a total shareholder equity of SEK34.5M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK51.0M and SEK16.5M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 41.80m |
| Equity | SEK 34.50m |
| Total liabilities | SEK 16.50m |
| Total assets | SEK 51.00m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0GQU's short term assets (SEK44.1M) exceed its short term liabilities (SEK12.1M).
Long Term Liabilities: 0GQU's short term assets (SEK44.1M) exceed its long term liabilities (SEK4.4M).
Debt to Equity History and Analysis
Debt Level: 0GQU is debt free.
Reducing Debt: 0GQU has no debt compared to 5 years ago when its debt to equity ratio was 269.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0GQU has sufficient cash runway for 9 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 0GQU is forecast to have sufficient cash runway for 10 months based on free cash flow estimates, but has since raised additional capital.